MAM
Joydeep Raha promoted as head Initiative Mumbai
MUMBAI: Lintas Media Group has promoted Joydeep Raha as head of Initiative Mumbai, which comes as an additional responsibility. At present, Raha heads Initiative Bangalore as associate vice president.
Describing his new assignment as “exciting, as well as immensely challenging,” Raha, who will be based in Mumbai now, said, “It is indeed a great task to head two branches of one of the country’s most dynamic media service practices. The Group’s knowledge based approach is very satisfying and I look forward to the challenges.”
Initiative president Kartik Iyer in an official statement said, “This year, we hope to take Initiative to new heights. To reach this, it is imperative to maintain the business on a positive path. According to me, Joydeep’s track record at the Bangalore branch makes him most apt for the job.”
Lintas Media Group media services director Lynn de Souza was quoted in the statement as saying, “We are always keen on providing opportunities for our people to grow and benefit. I’m sure this decision will prove correct and enhance Initiative’s move ahead.”
Raha has been with Initiative since October 2003, heading the Bangalore branch. His tenacity and perspective enabled him to bag the Birla 3M (makers of Scotchbrite and Scotchgard), Weekender, IIHT and MV Diabetic accounts last year.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
